Cargando…
Enoxaparin-sodium/heparin/tocilizumab: Masking of inflammatory markers following off-label use, and lack of efficacy and: 5 case reports
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644400/ http://dx.doi.org/10.1007/s40278-020-84893-x |